Stellar Biotechnologies, Inc. Uncategorized Contracts & Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities
Stellar Biotechnologies, Inc.
Biotechnology
2024
At The Market Offering Agreement, dated October 4, 2024, by and between Edesa Biotech, Inc. and H.C. Wainwright & Co., LLC
Stellar Biotechnologies, Inc.
Biotechnology
NY
2024
Strategic Innovation Fund Agreement, dated October 12, 2023, by and among Edesa Biotech Research, Inc., Edesa Biotech, Inc., and his Majesty the King in right of Canada as...
Stellar Biotechnologies, Inc.
Biotechnology
2023
Description of Securities
Stellar Biotechnologies, Inc.
Biotechnology
2023
Strategic Innovation Fund Agreement among Edesa Biotech Research, Inc., Edesa Biotech, Inc., and her Majesty the Queen in right of Canada as represented by the Minister of...
Stellar Biotechnologies, Inc.
Biotechnology
2021
Engagement Letter, dated as of April 9, 2018, between the Company and H.C. Wainwright & Co., LLC
Stellar Biotechnologies, Inc.
Biotechnology
NY
2018
SECURITIESPURCHASE AGREEMENT
Stellar Biotechnologies, Inc.
Biotechnology
NY
2016
SUBJECT TO COMMITMENTSCOMMITTEE APPROVAL
Stellar Biotechnologies, Inc.
Biotechnology
NY
2016
250North Ventura Road •Port Hueneme, California93041 • Phone(805) 986-6500
Stellar Biotechnologies, Inc.
Biotechnology
2015
CollaborationAgreement
Stellar Biotechnologies, Inc.
Biotechnology
CA
2015
STELLAR BIOTECHNOLOGIES,INC. (the “Company”) ADVANCE NOTICE POLICY (Initially adopted by the Board of Directors on October 31, 2013)
Stellar Biotechnologies, Inc.
Biotechnology
2014